HLN ConsultingInnovators in Health Informatics

Category Archives

50 Articles

New Version of HLN’s Award Winning Open Source Immunization Forecaster Released and Working on COVID-19 Vaccine Support

Share

New Version of HLN’s Award Winning Open Source Immunization Forecaster Released and Working on COVID-19 Vaccine Support

On November 6, 2020, HLN released a new version (v1.24.2) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open source software system that provides clinical ...

On November 6, 2020, HLN released a new version (v1.24.2) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

Data Management for Large-scale COVID-19 Immunization: This is all not as simple as it seems

Share

Data Management for Large-scale COVID-19 Immunization: This is all not as simple as it seems

Background and Introduction There is a global race for the development of a vaccine for the SARS-CoV-2 virus that causes COVID-19. Finding a vaccine that works and receives appr ...

Background and Introduction

There is a global race for the development of a vaccine for the SARS-CoV-2 virus that causes COVID-19. Finding a vaccine that works and receives approval is only part of the process. There are a series of other steps that need to be taken so that the vaccine can be delivered. These include the mass production of the vaccine, shipment, administration and record-keeping. This may be even more complex as there may be several vaccines.

In this article we review some of these issues with a particular focus on the United States.

Case Reporting and COVID-19: Open Source Solutions

Share

Case Reporting and COVID-19: Open Source Solutions

The United States is continuing its slow emergence from a nation-wide shut down imposed to slow down the spread of COVID-19. Most states have started to reopen, with bars, restaura ...

The United States is continuing its slow emergence from a nation-wide shut down imposed to slow down the spread of COVID-19. Most states have started to reopen, with bars, restaurants, and many workplaces starting to fill. As people begin to spend more time together again, it is critically important that public health agencies do everything they can to help prevent further spread of the infection and continue to monitor the level of infection within the population.

Senate White Paper: Preparing for the Next Pandemic

Share

Senate White Paper: Preparing for the Next Pandemic

On June 10, 2020 the US Senate released a white paper titled “Preparing for the Next Pandemic” under the signature of Senator Lamar Alexander of Tennessee. The white paper has five ...

On June 10, 2020 the US Senate released a white paper titled “Preparing for the Next Pandemic” under the signature of Senator Lamar Alexander of Tennessee. The white paper has five recommendations to address future pandemics based on lessons learned from COVID-19 and the past 20 years of pandemic planning. “The five recommendations…along with a series of questions at the end of this white paper, are intended to elicit recommendations that Congress can consider and act on this year,” Alexander said in a statement, adding that “I am inviting comments, responses, and any additional recommendations for the Senate Committee on Health, Education, Labor and Pensions to consider. This feedback will be shared with my colleagues, both Democrat and Republican.” This feedback from the public will be accepted until June 26, 2020 and can be submitted to PandemicPreparedness@help.senate.gov.

Leveraging the ICE Open Source Immunization Forecaster during COVID-19

Share

Leveraging the ICE Open Source Immunization Forecaster during COVID-19

Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in dev ...

Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in development, many of which are utilizing new technologies not used in any currently licensed vaccine. The potential impact on immunization schedules (clinical guidelines for clinicians) and immunization clinical decision support is significant.